Plasma Resilience: Europe's Lifeline
Medicines made from human plasma are crucial for treating various conditions, including rare inherited disorders and immunodeficiencies.
Human plasma, accounting for 55% of our blood, is essential for developing therapies, but Europe's supply chain is vulnerable.
- 12 million people across Europe donate plasma annually.
- Donations are governed by EU Member States, International Quality Plasma Program (IQPP), and the Plasma Protein Therapeutics Association (PPTA).
Despite this, nearly 40% of plasma used in Europe must be imported from the United States, highlighting the need to strengthen the supply chain.
Plasma is singularly human, existing only thanks to the generosity of real people.
Author's summary: Europe relies heavily on plasma donations for life-saving therapies.
More News
- Mosman poised to rebrand as Quantum Helium after £2.17m capital raise
- Watch: Jeff Tweedy Performs 'Twilight Override' Tracks and Talks New Triple Record on 'Colbert'
- Zanzibar must act to conserve its natural & cultural heritage for the future (commentary)
- OPINION: Pardons, clemency, and the death of moral clarity
- ‘Simplification’ drives EU policy agenda for 2026